41 results
8-K
EX-99.1
STRO
Sutro Biopharma Inc
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
portfolio, therapeutic areas of focus and commercial strategy.
“I am pleased to promote Jane into the leadership position created to optimize business … of Immuno-Oncology of US business at AstraZeneca. Ms. Chung held diverse senior leadership roles at AstraZeneca, Onyx, Genentech and Pharmacia. She started
8-K
EX-99.1
STRO
Sutro Biopharma Inc
9 Aug 21
Business Highlights and Anticipated Second Half 2021 Milestones
7:01am
is exploring the potential of conjugated vaccines utilizing the power of Sutro's cell-free technology.
Leadership Updates: Sutro continues … to strengthen leadership through the addition of a Chief Commercial Officer, promotion of a Chief Portfolio Strategy & Alliance Officer, and additions
PRE 14A
STRO
Sutro Biopharma Inc
14 Apr 23
Preliminary proxy
4:05pm
and Leadership Structure
The positions of Chief Executive Officer and Chair of our Board of Directors are held by two different individuals (William … the independence of the Board of Directors from management. Any changes to the leadership structure of our Board of Directors, if made, will be promptly disclosed
8-K
EX-99.1
uqeeoyqh15qj48fu
2 Apr 24
Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors
6:04am
8-K
EX-99.1
go88o2z9fxduk
25 Mar 24
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
EX-99.1
8otap dw17ytwm3
9 May 22
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
4:31pm
8-K
EX-99.1
38cv0n4e
30 Mar 23
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:32pm
8-K
EX-99.1
64dhrhahmqisxgp
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
EX-99.1
9ig7on
10 Aug 23
Sutro Biopharma Reports Second Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm
8-K
EX-99.2
w7l7l8vzaj sm4cbf1g
19 May 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
n7ei8
15 May 23
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
8:01am
8-K
EX-99.2
d2ii 9fglfsn
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
EX-99.1
3b47m
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
kvick4klhqmkbt
16 Jun 22
Other Events
7:00am
DEF 14A
20yx qgj0
26 Apr 19
Definitive proxy
12:00am